Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-09 Gift |
2025-04-10 4:01 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN Chief Executive Officer |
197,906 | $0 | 511,704 (Indirect) |
View |
| 2025-01-22 Option Award |
2025-01-24 4:10 pm |
N/A 2035-01-21 |
Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN Chief Executive Officer |
400,000 | $4.37 | 400,000 (Direct) |
View |
| 2024-01-24 Option Award |
2024-01-25 4:05 pm |
N/A 2034-01-23 |
Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN Chief Executive Officer |
300,000 | $3.06 | 300,000 (Direct) |
View |
| 2023-08-17 Gift |
2023-08-18 4:03 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN Chief Executive Officer |
63,000 | $0 | 511,704 (Direct) |
View |
| 2023-05-26 Gift |
2023-05-31 9:22 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN Chief Executive Officer |
300,000 | $0 | 448,704 (Indirect) |
View |
| 2022-02-10 Gift |
2023-02-22 4:23 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN Chief Executive Officer |
127,850 | $0 | 890,324 (Direct) |
View |
| 2022-10-25 Other |
2023-02-22 4:23 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN Chief Executive Officer |
189,310 | $0 | 890,324 (Direct) |
View |
| 2023-01-26 Option Award |
2023-01-30 5:02 pm |
N/A 2033-01-25 |
Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN Chief Executive Officer |
280,000 | $0 | 280,000 (Direct) |
View |
| 2022-09-16 Exercise |
2022-09-19 4:06 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN Chief Executive Officer |
40,000 | $0.54 | 930,629 (Direct) |
View |
| 2022-09-16 Exercise |
2022-09-19 4:06 pm |
N/A 2027-05-29 |
Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN Chief Executive Officer |
40,000 | $0 | 930,629 (Direct) |
View |
| 2022-01-26 Option Award |
2022-01-28 4:26 pm |
N/A 2032-01-25 |
Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN Chief Executive Officer |
440,000 | $0 | 911,704 (Direct) |
View |
| 2021-08-20 Exercise |
2021-08-23 5:01 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN Chief Executive Officer |
23,000 | $0.54 | 930,629 (Direct) |
View |
| 2021-08-20 Exercise |
2021-08-23 5:01 pm |
N/A 2027-05-29 |
Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN Chief Executive Officer |
23,000 | $0 | 930,629 (Direct) |
View |
| 2021-01-28 Option Award |
2021-02-01 9:23 pm |
N/A 2031-01-27 |
Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN See Remarks |
300,000 | $0 | 300,000 (Direct) |
View |
| 2020-10-27 Conversion |
2020-10-29 4:59 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN See Remarks |
50,450 | $0 | 25,225 (Indirect) |
View |
Ownership |
2020-10-22 8:45 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN See Remarks |
0 | $0 | 1,492,136 (Direct) |
View |